Abaxis Launches Quantitative Canine Lyme Disease Test

Posted: Tuesday, Dec. 27, 2011, 4:20 p.m. EST



Published:

Abaxis Inc. added a quantitative antibody test for canine Lyme disease to its line of tests available through the Abaxis Veterinary Reference Laboratories Division in Olathe, Kan., the company reported today.

The test measures a combination of antibodies to peptides which mimic certain antigens of the Borrelia burgdorferi spirochete. The antibodies are not found in vaccinated or noninfected patients, allowing for a definitive diagnosis of the disease, according to Kenneth Aron, Ph.D., Abaxis' chief technology officer.

The test may be used as a standalone diagnostic test to determine infection status or efficacy during treatment. It also may be used as a quantitative confirmation test for Abaxis’ upcoming VetScan Lyme Rapid Test, which is under development, according to the Union City, Calif.-based company.

<HOME>

Archive »Read More

Space Available in Golden Retriever Study

Morris Animal Foundation needs 1,000 more golden retrievers to participate in a long-term health study.

WSAVA Turns Focus to Animal Welfare

The World Small Animal Veterinary Association launches projects aimed at improving animal welfare.

Free Online ‘One Health’ Course Scheduled

One Health, emerging infectious diseases and other topics will be covered in a new online class from St. George’s University.

Add your comment:

Events


Show More...